Mechanical force-driven TNFα endocytosis governs stem cell homeostasis

Abstract

Mesenchymal stem cells (MSCs) closely interact with the immune system, and they are known to secrete inflammatory cytokines in response to stress stimuli. The biological function of MSC-derived inflammatory cytokines remains elusive. Here, we reveal that even under physiological conditions, MSCs produce and release a low level of tumor necrosis factor alpha (TNFα), which is unexpectedly required for preserving the self-renewal and differentiation of MSCs via autocrine/paracrine signaling. Furthermore, TNFα critically maintains MSC function in vivo during bone homeostasis. Mechanistically, we unexpectedly discovered that physiological levels of TNFα safeguard MSC homeostasis in a receptor-independent manner through mechanical force-driven endocytosis and that endocytosed TNFα binds to mammalian target of rapamycin (mTOR) complex 2 and restricts mTOR signaling. Importantly, inhibition of mTOR signaling by rapamycin serves as an effective osteoanabolic therapeutic strategy to protect against TNFα deficiency and mechanical unloading. Collectively, these findings unravel the physiological framework of the dynamic TNFα shuttle-based mTOR equilibrium that governs MSC and bone homeostasis.

References

[1] Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol., 2008, 8:726-736

[2] Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat. Immunol., 2014, 15:1009-1016

[3] Liu Y et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat. Med., 2011, 17:1594-1601

[4] Wang L et al. IFN-gamma and TNF-alpha synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkappaB signaling. Stem Cells, 2013, 31:1383-1395

[5] Ren G et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2008, 2:141-150

[6] Xu G, Zhang Y, Zhang L, Roberts AI, Shi Y. C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells. Stem Cells, 2009, 27:942-948

[7] Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE, 2010, 5

[8] Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell Physiol., 1996, 166:585-592

[9] Kinnaird T et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res., 2004, 94:678-685

[10] Ke F et al. Autocrine interleukin-6 drives skin-derived mesenchymal stem cell trafficking via regulating voltage-gated Ca(2+) channels. Stem Cells, 2014, 32:2799-2810

[11] Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood, 2012, 119:651-665

[12] Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J. Cell Biochem., 2018, 119:105-110

[13] Black RA et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 1997, 385:729-733

[14] Hohmann HP, Remy R, Poschl B, van Loon AP. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding. J. Biol. Chem., 1990, 265:15183-15188

[15] Huang H et al. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Prolif., 2011, 44:420-427

[16] Sui BD, Hu CH, Zheng CX, Jin Y. Microenvironmental views on mesenchymal stem cell differentiation in aging. J. Dent. Res., 2016, 95:1333-1340

[17] Ozcivici E et al. Mechanical signals as anabolic agents in bone. Nat. Rev. Rheumatol., 2010, 6:50-59

[18] Vining KH, Mooney DJ. Mechanical forces direct stem cell behaviour in development and regeneration. Nat. Rev. Mol. Cell Biol., 2017, 18:728-742

[19] Klein-Nulend J, Bacabac RG, Veldhuijzen JP, Van Loon JJ. Microgravity and bone cell mechanosensitivity. Adv. Space Res, 2003, 32:1551-1559

[20] Wang J et al. Mechanical stimulation orchestrates the osteogenic differentiation of human bone marrow stromal cells by regulating HDAC1. Cell Death Dis., 2016, 7

[21] Li P et al. Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibility. FASEB J., 2015, 29:3263-3273

[22] Yang R et al. Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter. Nat. Commun., 2018, 9

[23] Sui B et al. Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis. Sci. Rep., 2016, 6

[24] Liu D et al. Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors. Cell Res., 2018, 28:918-933

[25] Duque G et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells, 2009, 27:550-558

[26] Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med., 2006, 12:17-25

[27] Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J. Clin. Invest., 2007, 117:337-345

[28] Nandadasa S et al. Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis. Nat. Commun., 2019, 10

[29] Meng D, Frank AR, Jewell JL. mTOR signaling in stem and progenitor cells. Development, 2018, 145:dev152595

[30] Chen C et al. mTOR inhibition rescues osteopenia in mice with systemic sclerosis. J. Exp. Med., 2015, 212:73-91

[31] Raucher D, Sheetz MP. Membrane expansion increases endocytosis rate during mitosis. J. Cell Biol., 1999, 144:497-506

[32] Kiyoshima D, Kawakami K, Hayakawa K, Tatsumi H, Sokabe M. Force- and Ca(2)(+)-dependent internalization of integrins in cultured endothelial cells. J. Cell Sci., 2011, 124:3859-3870

[33] Kumari S, Mg S, Mayor S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res., 2010, 20:256-275

[34] Narayana YV, Gadgil C, Mote RD, Rajan R, Subramanyam D. Clathrin-mediated endocytosis regulates a balance between opposing signals to maintain the pluripotent state of embryonic stem cells. Stem Cell Rep., 2019, 12:152-164

[35] Zhang P et al. An SH3PX1-dependent endocytosis-autophagy network restrains intestinal stem cell proliferation by counteracting EGFR-ERK signaling. Dev. Cell, 2019, 49:574-589

[36] Martin SK et al. Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells, 2015, 33:1359-1365

[37] Chen C et al. Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res., 2017, 27:559-577

[38] Liu Y et al. Chronic high dose alcohol induces osteopenia via activation of mTOR signaling in bone marrow mesenchymal stem cells. Stem Cells, 2016, 34:2157-2168

[39] Halder G, Dupont S, Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol., 2012, 13:591-600

[40] Steffen JM, Musacchia XJ. Spaceflight effects on adult rat muscle protein, nucleic acids, and amino acids. Am. J. Physiol., 1986, 251:R1059-R1063

Funding

University of Pennsylvania (Penn)

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)(K99E025915)

China Postdoctoral Science Foundation